A competent professional with more than 15 years of experience in Research & Development, Quality Control, Quality Assurance and Project Management. At present working as Group Leader/Study Director at vivopharm and Senior Research Fellow at The University of Queensland after completing PhD on the pharmacokinetics of complement C5a receptor antagonists and neuroprotective barrier impairment studies in neurodegeneration. In the process of working on the preclinical development of novel therapeutics for neurodegenerative diseases, acquired various skill sets of quantitative and qualitative metabolomics, proteomics and lipidomics studies. Additionally, conducted various bioanalytical studies including method development and validation and study designing aimed at progressing new therapeutics towards clinical trials. Prior work experience includes Douglas Pharmaceuticals as Quality Control Analyst and Auckland Cancer Society Research Centre, Auckland University as a Research Technician. Experience in analysing/interpreting research results and technical data. Participated in various research projects with real-time experience in execution, various method development, and optimisation, application of methodologies, documentation, and presentation of findings. Possesses a detail-oriented attitude with a bio-analytical mind-set. A keen communicator with proven problem solving and analytical abilities.Specialties: • LC-MS/MS method development and optimisation for various therapeutic moieties including antibodies, linear and cyclic peptides, and various other small molecules (n>20)• Pharmacokinetic study expertise, including in-vivo animal surgeries, various routes of drug administrations, study designing, biodistribution, plasma PK using terminal bleed (cardiac puncture and renal artery) and serial sampling using DMPK cards and tail bleed. Data analysis with WINNONIN software and PKSolver platform.• Expertise in neuroprotective barrier assessment with disease progression and applicability towards benefits of therapeutic molecules in neurodegeneration• Knowledge of various analytical techniques such as MALDI, LC-MS/MS, HPLC, Scintillation, UV/Fluorescence, PCR, SDS- PAGE Electrophoresis, Gel Electrophoresis, ELISA and Protein Estimation Assays, etc • Knowledge of various regulatory approved platforms for ADME and Tox prediction such as GastroPlus, ADMET predictor, and MolSoft along with experiment setup for LogP, LogD, BP distribution, PPB, BPB, stability studies (including plasma, serum, gastric and intestinal matrix) and microsomal stability studies.